M Ferdeghini - Concepedia

Author

M Ferdeghini

Also Known As

CLERICO, ALDO, Ferdeghini M, G. Mariani, L Lennartz, M FERDEGHINI, M Ferdeghini, M. Ferdeghini, MARCO FERDEGHINI, Marco Ferdeghini, R. Palla

330

Publications

4.4K

Citations

H-Index

121

Concepts

All Affiliations

University of Pisa University of Verona Istituto di Fisiologia Clinica Ospedale Santa Chiara University of Milan

About

M Ferdeghini is an author at University of Pisa specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	49	1.9K
2	Health Sciences	12	13	553
3	Public Health	7	7	393
4	Engineering	1	1	19
5	Applied Physiology	1	1	31

M Ferdeghini

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Role of Neck Ultrasonography in the Follow-up of Patients Operated on for Thyroid Cancer Alessandro Antonelli, Paolo Miccoli, M Ferdeghini, Thyroid	1995	224
Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis A Pilo, Giorgio Iervasi, F. Vítek, American Journal of Physiology-Endocrinology and Metabolism Peripheral ProductionParathyroid DiseaseParathyroid GlandIodine Deficiency DisordersParathyroid Hormone	1990	187
Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement? Cosimo Durante, Teresa Montesano, Marco Attard, The Journal of Clinical Endocrinology & Metabolism	2012	159
Normal Volumetric Bone Mineral Density and Bone Turnover in Young Men with Histories of Constitutional Delay of Puberty Silvano Bertelloni, Giampiero I. Baroncelli, M Ferdeghini, The Journal of Clinical Endocrinology & Metabolism Bone DiseaseIm Testosterone DepotBone HealthBody CompositionOrthopaedic Surgery	1998	117
Plasma Cholesterol Regulates Soluble Cell Adhesion Molecule Expression in Familial Hypercholesterolemia Tiziana Sampietro, M. Tuoni, M Ferdeghini, Circulation	1997	113
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis Angiolo Gadducci, M Ferdeghini, Concetta Prontera, Gynecologic Oncology Concomitant DeterminationCancer DetectionEpithelial Ovarian CancerMedicineDifferent Tumor Markers	1992	110
Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas Cosimo Durante, Marco Attard, Massimo Torlontano, The Journal of Clinical Endocrinology & Metabolism	2010	105
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma Giovanni Butturini, Rossella Bettini, Edoardo Missiaglia, Endocrine Related Cancer	2006	101
Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues Silvano Bertelloni, Giampiero I. Baroncelli, M Ferdeghini, European Journal of Pediatrics Bone HealthFertilityBody CompositionFinal HeightCentral Precocious Puberty	2000	99
Long-Acting Depot Lanreotide in the Treatment of Patients With Advanced Neuroendocrine Tumors Serafino Ricci, Andrea Antonuzzo, Luca Galli, American Journal of Clinical Oncology	2000	98

Page 1